BDBM790979 US20260034252, Compound RTX-1316R

SMILES CC(C)Cc1ccc(CC(=O)NCCCCC(NC(=O)[C@@H](CCCCNC(=S)Nc2ccc(C[C@H]3CN(C(=O)O)CCN(CC(=O)O)CCN3CC(=O)O)cc2)NC(=O)CCOCCOCCOCCNC(=O)COc2ccc3c(C(=O)NCC(=O)N4CCCC4C#N)ccnc3c2)C(=O)O)cc1

InChI Key

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 790979   

TargetProlyl endopeptidase FAP(Human)
Ratio Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 790979BDBM790979(US20260034252, Compound RTX-1316R)
Affinity DataIC50: 2.75nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details US Patent